| 2019 | | Association Between Radiation Tolerance of Lymphocytes and Clinical Outcomes in Cervical Cancer | 공태욱, 이용희, 이은주, 장석준, 전미선, 조오연 |
| 2017 | | Clinical Impact of Escalating Relative High-dose-rate Intracavitary Brachytherapy Dose in Stage IIB Cervical Cancer | 노오규, 오영택, 장석준, 전미선, 조오연 |
| 2017 | | Hematological parameters during concurrent chemoradiotherapy as potential prognosticators in patients with stage IIB cervical cancer | 노오규, 오영택, 유희석, 이은주, 장석준, 전미선, 조오연 |
| 2017 | | Long-term results of early adjuvant concurrent chemoradiotherapy for high-risk, early stage uterine cervical cancer patients after radical hysterectomy | 공태욱, 오영택, 유희석, 장석준, 전미선 |
| 2021 | | Magnetic resonance imaging-based validation of the 2018 FIGO staging system in patients treated with definitive radiotherapy for locally advanced cervix cancer | 정승연 |
| 2000 | | Modified partial hyperfractionation in radiotherapy for bulky uterine cervical cancer: reduction of overall treatment time. | 강승희, 오영택, 유희석, 이은주, 장기홍, 전미선, 주희재 |
| 2019 | | Para-aortic lymph node recurrence after curative radiotherapy for cervical cancer | 양경미 |
| 2016 | | Patterns of recurrence and survival after abdominal versus laparoscopic/robotic radical hysterectomy in patients with early cervical cancer | 공태욱, 백지흠, 유희석, 이용희, 이은주, 장석준, 전미선 |
| 2024 | | Post-Radiotherapy Exosomal Non-Coding RNA and Hemograms for Early Death Prediction in Patients with Cervical Cancer | 조오연 |
| 2005 | | Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients. | 유희석, 이정필, 장기홍, 장혜진, 전미선 |
| 2016 | | Preoperative nomogram for prediction of microscopic parametrial infiltration in patients with FIGO stage IB cervical cancer treated with radical hysterectomy | 공태욱, 백지흠, 손주혁, 유희석, 장석준, 전미선 |
| 2015 | | Pretreatment serum CYFRA 21-1 level correlates significantly with survival of cervical cancer patients: a multivariate analysis of 506 cases. | 공태욱, 백지흠, 유희석, 장석준, 전미선 |
| 2017 | | Prognostic implication of simultaneous anemia and lymphopenia during concurrent chemoradiotherapy in cervical squamous cell carcinoma | 노오규, 오영택, 유희석, 이은주, 장석준, 전미선, 조오연 |
| 2016 | | Prognostic Value of Severe Lymphopenia During Pelvic Concurrent Chemoradiotherapy in Cervical Cancer | 노오규, 오영택, 장석준, 전미선, 조오연 |
| 2004 | | Rectal bleeding and its management after irradiation for uterine cervical cancer. | 강승희, 오영택, 유희석, 전미선 |
| 2017 | | Salvage radiotherapy with or without concurrent chemotherapy for pelvic recurrence after hysterectomy alone for early-stage uterine cervical cancer | 공태욱, 오영택, 유희석, 이용희, 이은주, 장석준, 전미선 |
| 2021 | | Screening plasma exosomal RNAs as diagnostic markers for cervical cancer: An analysis of patients who underwent primary chemoradiotherapy | 정재연, 조오연 |
| 2004 | | Synchronous coexpression of epidermal growth factor receptor and cyclooxygenase-2 in carcinomas of the uterine cervix: a potential predictor of poor survival. | 전미선 |
| 2018 | | The Prognostic Impact of the Number of Metastatic Lymph Nodes and a New Prognostic Scoring System for Recurrence in Early-Stage Cervical Cancer with High Risk Factors: A Multicenter Cohort Study (KROG 15-04) | 전미선 |
| 2016 | | Treatment outcomes in patients with FIGO stage IB-IIA cervical cancer and a focally disrupted cervical stromal ring on magnetic resonance imaging: A propensity score matching study | 공태욱, 백지흠, 손주혁, 유희석, 장석준, 전미선 |
| 2011 | | Treatment patterns and outcomes in bulky stage IB2 cervical cancer patients: a single institution's experience over 14 years. | 김우영, 유승철, 유희석, 장기홍, 장석준, 전미선 |
